Resumo

MARTINEZ CORDOVA, Zuzet  e  PENA FRESNEDA, Natacha. Prevalence of anti-HCV antibodies and of the hepatitis B surface antigen in patients treated with hemodialysis. Rev cubana med [online]. 2008, vol.47, n.1. ISSN 0034-7523.

108 hemodialysis patients were studied to determine the prevalence of antibodies against hepatitis C virus (anti-HCV) and of the hepatitis B surface antigen (HBsAg) by using the SUMA technology. It was obtained an elevated prevalence of antibodies against the hepatitis C virus (90 %) and a lower prevalence of of HBsAg (4 %). Titres protecting anti-HBsAg antibodies were found in 91 % of the patients. It was observed that the patients with antibody levels of 10 UI/L were protected, which corresponds to an effective response to our vaccination scheme and to better results than the ones normally reported for this type of patient (100 UI/L). Persistently normal values of the enzymatic activity of the glutamic piruvic enzyme (GPT) were present in 65 % of the patients, which could indicate a chronic disease and corroborate the frequent decrease observed in the enzymatic activity of GPT.

Palavras-chave : Hemodializados; anti-VHC; HBsAg; anti-HBsAg; TGP; Hemodialysis patients; anti-HCV; anti-HBsAg; GPT.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )